Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Change in Receivables (2022 - 2025)

Envoy Medical's Change in Receivables history spans 4 years, with the latest figure at -$758000.0 for Q4 2025.

  • Quarterly results put Change in Receivables at -$758000.0 for Q4 2025, down 201.34% from a year ago — trailing twelve months through Dec 2025 was -$761000.0 (down 225.99% YoY), and the annual figure for FY2025 was -$761000.0, down 225.99%.
  • Change in Receivables for Q4 2025 was -$758000.0 at Envoy Medical, down from -$8000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $762000.0 in Q2 2025 to a low of -$758000.0 in Q4 2025.
  • The 4-year median for Change in Receivables is -$4000.0 (2024), against an average of -$2846.2.
  • Peak annual rise in Change in Receivables hit 19150.0% in 2025, while the deepest fall reached 425.69% in 2025.
  • Year by year, Change in Receivables stood at -$56000.0 in 2022, then surged by 292.86% to $108000.0 in 2023, then soared by 592.59% to $748000.0 in 2024, then plummeted by 201.34% to -$758000.0 in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$758000.0, -$8000.0, and $762000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.